Putnam Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

Putnam Investments’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$14.9M	Buy	239,360 +62,669	+35%	+$3.51M	0.02%	267
2023 Q3	$9.92M	Buy	176,691 +39,964	+29%	+$2.25M	0.02%	314
2023 Q2	$6.9M	Buy	136,727 +6,766	+5%	+$360K	0.01%	386
2023 Q1	$7.09M	Buy	129,961 +427	+0.3%	+$24.9K	0.01%	379
2022 Q4	$8.1M	Buy	129,534 +706	+0.5%	+$46.9K	0.01%	334
2022 Q3	$9.07M	Sell	128,828 -578	-0.4%	-$39.9K	0.02%	307
2022 Q2	$7.33M	Sell	129,406 -25,810	-17%	-$1.41M	0.01%	361
2022 Q1	$9.72M	Buy	155,216 +3,032	+2%	+$163K	0.01%	348
2021 Q4	$8.52M	Buy	152,184 +1,899	+1%	+$116K	0.01%	410
2021 Q3	$9.78M	Sell	150,285 -327	-0.2%	-$22.3K	0.02%	368
2021 Q2	$9.55M	Hold	150,612	–	–	0.01%	383
2021 Q1	$9.02M	Buy	+150,612	New	+$8.19M	0.02%	390

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Putnam Investments's AXNX Position: Q4 2023 in Review

Putnam Investments increased its Axonics, Inc. Common Stock (AXNX) stake by 35% in Q4 2023, buying an estimated $3.51M and bringing the position to 239,360 shares worth $14.9M. The position accounts for 0.02% of the portfolio, ranked #267.

Putnam Investments first reported a position in AXNX in Q1 2021 and has held it in 12 quarters since. 230 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

Putnam Investments held 239,360 shares of Axonics, Inc. Common Stock worth $14.9M as of Q4 2023.
Putnam Investments bought 62,669 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $3.51M.
Axonics, Inc. Common Stock made up 0.02% of Putnam Investments's portfolio in Q4 2023, its #267 holding.
Putnam Investments first reported a position in Axonics, Inc. Common Stock in Q1 2021 and has held it in 12 quarters since.
230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.